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Confocal Microscopy of the Skin in the Diagnosis of X-Linked
Alport Syndrome
To the Editor:
Alport syndrome is an inherited disorder of type IVcollagen, the
major collagenous constituent of basement membranes (Timpl
and Brown, 1996).The hallmark of the disease is persistent micro-
scopic hematuria, often associated with proteinuria, progressive
renal failure, ocular abnormalities, and high-tone sensorineural
hearing loss (Kashtan, 1998). The majority (about 85%) of Alport
kindred show X-linked dominant inheritance, which is caused by
mutations in the COL4A5 gene located in the Xq22 region that
encodes for the a5(IV) chain of type IVcollagen (Mochizuki et al,
1994; Renieri et al, 1996). Mutations of the COL4A5 gene result in
the loss of a5(IV) chain in basement membranes (Yoshioka et al,
1994); in general, absence of a5(IV) expression in a male patient,
or a mosaic distribution in a female, is diagnostic of X-linked
Alport syndrome (Grunfeld, 2000).
a5(IV) is present in normal glomerular basement membrane
(GBM) and also in the normal epidermal basement membrane
(EBM) (Peissel et al, 1995); its absence results in typical ultrastruc-
tural lesions of the GBM, virtually diagnostic of the disease,
whereas no morphologic abnormalities have been observed in
the EBM (Kashtan et al, 1986; Nakanishi et al, 1994).
Immunohistochemical study of the skin, however, is at present
considered the procedure of choice in evaluating a patient with
microhematuria who is suspected of having X-linked Alport syn-
drome, being much less invasive than renal biopsy. Absence of
a5(IV) in the EBM, observed in nearly 80% of hemizygotes, or
a segmental pattern in heterozygotes, is diagnostic of the syn-
drome (Kashtan, 1998; Kashtan, 1999; Pirson, 1999; Grunfeld,
2000).
Unfortunately, in most published series a number of patients
exist in whom COL4A5 mutations are associated with a positive,
linear staining (Kashtan and Michael, 1996; Kashtan, 1998; 1999).
Immunohistochemical demonstration of a5(IV) expression is
currently achieved by the standard indirect immuno£uorescence
method, a simple and highly speci¢c technique. Yet, standard
£uorescence microscopy has a somewhat low resolving power,
depending upon the use of relatively thick (4^6 mm) tissue
sections.
The aim of this study was to verify whether the use of alter-
native microscopy techniques for immuno£uorescence could pre-
vent the occurrence of ‘‘false negative’’ results. This was achieved
by confocal laser scanning microscopy (CLSM), which produces
high-resolution images of thick biologic samples (Paddock, 1999).
We selected from a total of 45 probands with proven X-linked
Alport syndrome those cases in which routine immuno£uores-
cence for a5(IV) revealed a positive, linear, and continuous stain-
ing pattern. Eight symptomatic patients were studied (four males
and four females); clinical and molecular data are summarized in
Table I. The diagnosis was based on the identi¢cation of a muta-
tion on the COL4A5 gene and/or on the presence of the typical
ultrastructural lesions of the GBM in renal biopsies performed on
the patient or on an a¡ected relative. Two patients (#1 and #4)
had a negative family history, but showed a COL4A5 mutation
and a typical ultrastructural appearance of the GBM. In patient
#2 a COL4A5 mutation was not identi¢ed but a typical family
history was present (her child displayed a negative a5(IV) staining
along the GBM). All male patients but one (#8) had proteinuria;
conversely, proteinuria was present only in one female patient
(#3). Renal function was normal in all patients. Mild neurisensor-
ial deafness and a lens opacity was present in patient #6. Our
work was performed with full approval of our institution and all
experiments were conducted in compliance with the Helsinki
Principles for laboratory work with human tissue.
Punch (3 mm) skin biopsies were performed at the axillary
fold in six patients, and in three patients skin tissue was obtained
during percutaneous renal biopsy. Mean age at biopsy was 23.2 y
(range 6^45 y). Informed consent was obtained from all patients
and/or their parents.
Un¢xed skin samples were embedded in OCT, snap frozen in
liquid-nitrogen-cooled isopentane, and stored at ^801C until
used.Ten samples of normal skin were obtained as controls at sur-
gery from patients with malignant tumors (squamous cell carci-
noma or melanoma). Immunohistochemistry was performed
using monoclonal antibodies against a1(IV) and a5(IV) chains
(Weislab, Lund, Sweden). Sections of all patients and controls
were independently examined by two observers with a Nikon
microscope equipped with epi£uorescence illumination optics.
The same sections were subsequently examined with a Sarastro
2000 confocal laser scanning microscope by a third investigator,
without knowledge of the specimen category (patients versus
controls).
Results of conventional £uorescence microscopy con¢rmed in
all cases of Alport syndrome the presence of a linear, uninter-
rupted signal for a5(IV). Confocal microscopy, performed on
the same specimens, revealed that the pattern of distribution of
a5(IV) was indeed abnormal, with the three-dimensional recon-
struction of the EBM appearing as a discontinuous sheet.The dis-
rupted pattern varied from focal interruptions (i.e., small to
medium sized areas of negative staining, mostly linear in shape,
irregularly distributed along the whole length of the examined
EBM) to a coarsely granular distribution of the £uorescent dye
(i.e., large, irregularly shaped areas of negative staining sur-
rounded by rims or spots of positive staining) (seeTable II and
LETTERS TO THE EDITOR
Reprint requests to: Andrea Onetti Muda, M.D., Dipartimento di Med-
icina Sperimentale e Patologia, UniversitaØ La Sapienza,Viale Regina Elena,
324 (Policlinico) I-00161 Roma, Italy; Email: andrea.onettimuda@
uniroma1.it
Abbreviations: CLSM, confocal laser scanning microscopy; EBM, epi-
dermal basement membrane; GBM, glomerular basement membrane.
Manuscript received July 15, 2002; revised January 28, 2003; accepted for
publication February 6, 2003
208 MCKENZIE ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Fig 1 for details of each case). CLSM reconstruction of skin sam-
ples from control cases, in contrast, always exhibited a homoge-
neous, uninterrupted pattern of distribution (Fig 2). As expected,
immunohistochemical distribution of a1(IV) chain along the EBM
was not di¡erent in Alport cases and in controls (not shown).
Our study shows that the apparently normal skin distribution
of a5(IV) chain in a number of X-linked Alport patients is the
consequence of an optical artifact. Such false negative cases can
be the consequence of ‘‘minor’’ mutations a¡ecting the COL4A5
gene (Naito et al, 1996; Jais et al, 2000), or the result of random
inactivation of the X chromosome, in which a high proportion
of cells carry a normal, activated chromosome (Guo et al, 1995;
Belmont, 1996). Whatever mechanism is at work, the result is a
segmental distribution pattern, with smaller areas without signal
surrounded by a positive staining. Such distribution is easily
overlooked by conventional £uorescence microscopy.
Figure1. Immunohistochemical localization of a5(IV) chain in the skin of Alport cases.Thick (15^20 mm) cryostat sections of frozen tissues were
¢xed in acetone and stained by the indirect method; primary antibodies were diluted 1:50 (a1(IV)) or 1:5 (a5(IV)) in phosphate-bu¡ered saline with 0.5%
bovine serum albumin. Incubation was carried out for 1 h at room temperature, followed by 30 min incubation with 1:20 solution of £uorescein isothio-
cyanate conjugated secondary antibody (Dako, Glostrup, Denmark). Sections for a5(IV) immunostaining were denatured in 6 M urea 0.1 glycine HCl
bu¡er, pH 3.5, 30 min at room temperature, before the immune reaction. Optical sectioning was performed in three di¡erent areas of each specimen (two
at the extremities of the skin fragment and the third in the middle portion) using a 60 oil immersion objective; vertical and horizontal scans were made at
0.5 mm intervals and 30 images were reconstructed through ImageSpace software (Molecular Dynamics). (a), (b) case #1; (c), (d) case #2; (e), (f) case #3; (g),
(h) case #4; (i), (j) case #5; (k), (l) case #6; (m), (n) case #7; (o), (p) case #8. In each case, the reconstructed image is observed in front view (left) or has
been partially rotated, showing the specimen from the top (right). Focal interruptions are best appreciated in the partially rotated images (see alsoTable II
for detailed description). Bar: 20 mm.
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Use of confocal microscopy allowed us to demonstrate that the
apparent linearity of the £uorescent signal along the EBM was
the result of an artifact; in a two-dimensional view, a negative
spot that is positioned along the optical path of a positive signal
will be prevented from being visible, conferring on the specimen
an overall appearance of continuity. Three-dimensional recon-
struction of the EBM, followed by rotation along its axis, made
observation from di¡erent angles possible, thus revealing the hid-
den features of the region of interest. The sensitivity of immuno-
£uorescence study of skin biopsies is greatly improved, and the
number of false negative results is virtually eliminated.
An intriguing point of our study is the ¢nding of a segmental
distribution pattern in a¡ected male patients, and a convincing
explanation is not available. Faint staining for a5(IV) chain has
been described in male patients with COL4A5 mutations, how-
ever (Nakanishi et al, 1994; Naito et al, 1996), and the possibility
exists that the use of a more accurate detection system like CLSM
may reveal small areas of improper formation/incorporation of
the triple helix.
The approach currently recommended to con¢rm a suspec-
ted diagnosis of Alport syndrome calls for the study of a5(IV)
skin expression, followed, if not diagnostic, by kidney biopsy
(Kashtan, 1999). Our data indicate that CLSM examination of
the same tissue fragment could reveal a segmental diagnostic pat-
tern, therefore postponing, or even preventing, a more invasive
diagnostic procedure, and should be considered before kidney
biopsy.
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Table II. a5(IV) chain distribution along the EBM
Patient Standard £uorescence microscopy Confocal microscopy and three-dimensional reconstruction
1 Di¡use, homogeneous Focal interruptions, small size, mostly linear, along the EBM
2 Di¡use, homogeneous Focal interruptions, small size, irregular shape, along the EBM
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Figure 2. Normal human skin. Cryostat section immunostained for
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nate conjugated secondary antibody. (a), (b) Three-dimensional reconstruc-
tion of 30 consecutive optical sections; the reconstructed image is observed
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Table I. Clinical and molecular data
Patient Sex Age at biopsy (y) Family history Microscopic hematuria Hearing loss Ocular lesions Mutation Name Exon Reference
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7 M 25 þ þ   c.IVS14þ 2T4C 4 (IVS)
8 M 6 þ þ   p.P212del 11
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High Seroprevalence of Anti-Mycoplasma Fermentans Antibodies
in Patients with Malignant Aphthosis
To the Editor:
Mycoplasmas are wall-less bacteria causing infections of mucosal
tissue. Many mycoplasmas are commensals, others, such as Myco-
plasma (M) fermentans, are associated with rheumatoid arthritis
and other joint disorders (Schaeverbeke et al, 1996). Most, if not
all, mycoplasmas contain macrophage activating components.
Studies on a macrophage activator from mycoplasmas, compar-
able in activity with the lipopolysaccharide of gram-negative
bacteria, led to the identi¢cation of macrophage-activating lipo-
peptide (MALP)-2 from M. fermentans. MALP-2 is a small lipo-
peptide originating from MALP-404, a 40 kDa large lipoprotein
(Calcutt et al, 1999). MALP-2 and other mycoplasmal lipoproteins
have an unusual N-terminus. It consists of a cystein bearing a di-
hydroxypropyl group in thioether linkage. Both hydroxy groups
are esteri¢ed with long chain fatty acids, whereas the amino
group is free. This distinguishes mycoplasmal lipoproteins from
those in walled bacteria. Mycoplasmal lipoproteins are exception-
ally good antigens, because they have a built-in adjuvant site in
the form of the lipid-substituted N-terminus. Thus, MALP-404
is an immunodominant determinant in M. fermentans. MALP-
404 is expressed by most M. fermentans strains, including those
isolated from the joints of patients with reactive arthritis (Mˇhl-
radt, unpublished).
Like other bacterial proteins, MALP-404 contains the peptide
motif -G- - - - - -F, which can be presented by HLA-B51 (Falk et al,
1995). This transplantation antigen is associated with malignant
aphthosis (Sakane et al, 1999). Malignant aphthosis (Adamantiades^
Behc et’s disease) is a chronic, multisystemic in£ammatory disor-
der, which is clinically characterized by relapsing oral aphthous
and genital ulcers, ocular, and vascular lesions. The disease may
a¡ect small and large vessels in almost all organs. Malignant
aphthosis is a universal rare disorder with varying prevalence, oc-
curring endemically in the Eastern Mediterranean area and in Cen-
tral and East Asia, with a peak onset in the third decade of life
(Zouboulis, 1999). A microbial infection has been implicated in the
development of the disease to explain the strong in£ammatory re-
actions observed (Zouboulis and May, in press), the activation of
monocytes and macrophages, and the induction of proin£amma-
tory cytokines and chemokines detected (Zouboulis et al, 2000;
Alpsoy et al, 2003). Recently, several reports demonstrated that
crude fractions of lipoproteins derived from di¡erent mycoplasma
strains showed macrophage-stimulatory activities by inducing the
production of proin£ammatory cytokines. For all these reasons,
we investigated the presence of antibodies against MALP-404 in
the sera of patients with malignant aphthosis and examined a pos-
sible correlation of M. fermentans infection with the disease in an
ethic committee-approved case^control study.
The 22 patients [(10 female, 12 male; median age 37 y; originat-
ing from Germany (n¼ 3), Turkey (n¼12), and other countries
(n¼ 7)] and 14 gender-, age-, and land of origin-matched healthy
controls [(seven female, seven male; median age 36 y; originating
from Germany (n¼ 4), Turkey (n¼ 7), and other countries
(n¼ 3)] were recruited after providing written consent. Patients
ful¢lled the criteria of the International Study Group for Behc et’s
Disease (1990). The presence of the MALP-404 antigen was de-
tected in the serum of the subjects examined by the western blot
method. Demographic and background characteristics were dis-
played using summary statistics.The primary and secondary vari-
ables were evaluated using w2 tests. For all comparisons, a
signi¢cance level of 0.05 was applied.
From the 22 patients with malignant aphthosis, seven (32%)
were MALP-404-positive; among them three patients (14%) with
Figure1. Western blot of selected sera from patients with malignant
aphthosis (Adamantiades^Behc et’s disease). Mycoplasma lipoprotein
antigens were enriched by cold octyl glucoside extraction of aM. fermentans
strain isolated from the knee joint of a rheumatoid arthritis patient. The
antigen mixture was separated on sodium dodecyl sulfate^polyacrylamide
gel electrophoresis and electroblotted to a PVDF membrane. Lanes 1 to 4:
sera from patients with malignant aphthosis; lane 5: monoclonal antibodies
against the indicated lipoproteins (positive control); lane 6: molecular
weight markers. Note typical positive reaction to MALP-404 in lane 2,
and strong reaction with an unidenti¢ed M. fermentans antigen in lane 1.
Address correspondence and reprint requests to: Prof. Dr. Christos C.
Zouboulis, Department of Dermatology, University Medical Center Ben-
jamin Franklin, The Free University of Berlin, Fabeckstrasse 60-62, 14195
Berlin, Germany. Email: zouboulis@medizin.fu-berlin.de
Abbreviations: M, mycoplasma; MALP, macrophage-activating lipopeptide.
Manuscript received October 2, 2002; revised October 17, 2002; accepted
for publication January 23, 2003
LETTERS TO THE EDITOR 211VOL. 121, NO. 1 JULY 2003
